U.S., Dec. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07291141) titled 'A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis' on Dec. 05.
Brief Summary: DETECT-HCC-ESLD is a prospective multicenter study designed to examine early detection and risk stratification of hepatocellular carcinoma (HCC) in individuals with advanced liver disease. Adults with cirrhosis of different etiologies are enrolled and followed longitudinally with structured clinical assessments and imaging at predefined intervals.
A key objective is to evaluate ultrasound and abbreviated MRI (AMRI) as surveillance modalities ...